Publications by authors named "Steven R. Feldman"

Claim this Profile
S
Some cost-conscious care strategies for dermatology.
Sujeeth K Shanmugam, Serene Majid, Steven R Feldman

J Dermatolog Treat· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are potential remittive properties of OX-40 inhibitors something to be excited about?
Eliza Dewey, Steven R Feldman

J Dermatolog Treat· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on Practical Interventions to Optimize Patient Adherence in Dermatologic Surgery and Mohs Micrographic Surgery.
Chenan A Huang, Steven R Feldman, Laura B Doerfler

Dermatol Surg· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Garadacimab-gxii-A Novel Prophylactic Treatment for Hereditary Angioedema: A Drug Review.
Kelli M Schindel, Omar Raheel, Chenan A Huang, Steven R Feldman, Anette Bygum

Ann Pharmacother· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To test or not to test? Revisiting the value of baseline screening and monitoring tests among biologic treatments for psoriasis using an evidence-based assessment.
Jessica Q Duong, Dillon J Razler, Matthew L Hrin, William W Huang, Steven R Feldman

J Am Acad Dermatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the cardiovascular event and mortality rate difference between TNF-α vs. IL-12/23 inhibitors in patients with psoriasis clinically meaningful?
Seraphima Sidhom, Jonathan Greenzaid, Steven R Feldman

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical treatment adherence and writing clarity: insights from a precision dispenser study.
Sabine L Abukhadra, Robin C Yi, Steven R Feldman

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the quantity of topical corticosteroids applied reduces the severity of psoriasis: results from two randomized controlled trials.
Mathias Tiedemann Svendsen, Sören Möller, Steven R Feldman, Klaus Ejner Andersen

Clin Exp Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotics, analgesics and antifungals are commonly implicated in acute generalized exanthematous pustulosis; a retrospective analysis of 1410 cases.
Gaurav N Pathak, Aryan Mahajan, Steven R Feldman

Clin Exp Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression From Cutaneous Abscess to Hidradenitis Suppurativa: A Retrospective Analysis.
Hiral Patel, Sujeeth Krishna Shanmugam, Katie K Lovell, Madison Read, Elizabeth Swain, Steven R Feldman

Dermatol Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter Regarding: "Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study".
Chiara Tognaccini, Leah E Thomas, Dina Ghanim, Steven R Feldman, Jashin J Wu

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we be optimistic for the development of new psoriasis therapies?
Anna K Martino, Alice L Mikulinsky, Robin C Yi, Steven R Feldman

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on "Risk of autoimmune thyroid diseases in individuals with alopecia areata".
Brett R Shaffer, Erin Lee, Steven R Feldman

J Dtsch Dermatol Ges· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to comparison of relative remission rates of systemic therapies for moderate-to-severe plaque psoriasis.
Eliza J Dewey, Steven R Feldman, Arash Mostaghimi

J Invest Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Biosimilar Therapies for Psoriasis in Head-to-Head Trials.
Logan R Smith, Steven R Feldman

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab-lbkz for the Treatment of Atopic Dermatitis: A Drug Review.
Danial Nasim, Brett Shaffer, Steven R Feldman

Ann Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Characterization of the Relationship Between Field Cancerization and Number of Actinic Keratoses.
Stuti Prajapati, Christina Kontzias, Mallory Zaino, Steven R Feldman

J Cutan Med Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower oncogenic risk with dermatologic use of mycophenolate mofetil compared with transplant prophylaxis: A retrospective study.
Robin C Yi, Ainsley J Ruley, Aishwarya Sharma, Matthew L Hrin, Steven R Feldman

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial.
Jacek C Szepietowski, Adam Reich, Steven R Feldman, Grazyna Pulka, Lally Mekokishvili

Expert Opin Biol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Papp et al, "Efficacy and safety of ESK-001, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: 52-week results from the long-term phase 2 study in patients who participated in the phase 2 STRIDE study".
Christiaan H Noot, Zachary H Hopkins, Steven R Feldman

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation.
April W Armstrong, George C Gondo, Joseph F Merola, Alyssa M Roberts, Lourdes M Pérez-Chada, Steven R Feldman

JAMA Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study.
Jacek C Szepietowski, Adam Reich, Steven R Feldman, Grazyna Pulka, Lally Mekokishvili

Expert Opin Biol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Based on Hospital Admission Type.
Robin C Yi, Eunheh Koh, Elizabeth C Swain, Ainsley J Ruley, Christina Avila, Steven R Feldman

Cutis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Molluscum Treatment Options: Overcoming the Challenge of Poor Adherence.
Yasir Al-Dojaily, Steven R Feldman

J Clin Aesthet Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of anchoring on patients' likeliness to take an injection treatment for hidradenitis suppurativa.
Aaron D Smith, Catherine E Lyons, Katie Lovell, Diem-Phuong D Dao, Steven R Feldman

Dermatol Online J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis